Concepedia

Christopher R. Reilly

CR

Statistics

Publications

8

Citations

500

H-Index

8

Active since

2017

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Harvard Stem Cell Institute

Broad Institute

Christopher R. Reilly is an author at Dana-Farber Cancer Institute specializing in hematology, medicine, and myelodysplastic syndromes.

ORCID

Publications per year

2017–2025

8

Publications

8

Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms

Debra Van Egeren, Javier Escabi, Maximilian Nguyen et al. · Cell stem cell · 2021 · 209 citations · Full text

, , +17

Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells

Neha Nagpal, Jianing Wang, Jing Zeng et al. · Cell stem cell · 2020 · 101 citations · Full text

, , +10

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Mikko Myllymäki, Robert Redd, Christopher R. Reilly et al. · Blood · 2020 · 50 citations · Full text

, , +15

The clinical and functional effects of <i>TERT</i> variants in myelodysplastic syndrome

Christopher R. Reilly, Mikko Myllymäki, Robert Redd et al. · Blood · 2021 · 49 citations · Full text

, , +13

Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia

Andrew A. Lane, Jacqueline S. Garcia, Evangeline G. Raulston et al. · Blood Advances · 2023 · 45 citations · Full text

, , +14

1–5 of 8